Celsis In Vitro, Inc. v. CellzDirect, Inc.
United States Court of Appeals for the Federal Circuit
664 F.3d 922 (2012)
- Written by Samantha Arena, JD
Facts
Celsis In Vitro, Inc. (Celsis) (plaintiff) patented a method of preserving liver cells, or hepatocytes, through freezing the cells cryogenically several times. This patented technique made more hepatocytes available to research scientists. The method also made it possible to provide scientists with samples consisting of a pool of hepatocytes from multiple donors who had died at different times. Celsis sold a product practicing its patent, LiverPool, to researchers. CellzDirect, Inc. (defendant) and Invitrogen Corporation, which later became Life Technologies Corporation (LTC) (defendant), also sold pooled multi-cryopreserved hepatocyte products. Celsis sued LTC for patent infringement, alleging that LTC created its products using the same method that was patented by Celsis. The district court granted Celsis a preliminary injunction against LTC. LTC appealed.
Rule of Law
Issue
Holding and Reasoning (Rader, C.J.)
Dissent (Gajarsa, J.)
What to do next…
Here's why 807,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.